FACIT applauds quizartinib approval: a success for leukemia patients and Canadian cancer research translation

July 24, 2023 – The U.S. FDA announced the approval of quizartinib, an important new therapy for patients with leukemia. This global effort to impact patients in need is to be celebrated while recognizing the contributions from across the Canadian health R&D ecosystem to reach this significant milestone that will now make a difference for patients.

Read More from FACIT applauds quizartinib approval: a success for leukemia patients and Canadian cancer research translation

Registration is now open for FACIT Falcons’ Fortunes pitch competition and reception

February 21, 2023 – This year marks the 10th anniversary of the FACIT Falcons’ Fortunes pitch competition! Be part of the audience and watch the six finalists pitch their Ontario oncology innovations.

Read More from Registration is now open for FACIT Falcons’ Fortunes pitch competition and reception